Pluristem Therapeutics (PSTI) receives FDA orphan status for aplastic anemia treatment
- eBay (EBAY) to Spin PayPal into Separate, Publicly-Traded Company
- Walgreens (WAG) Reports In-Line Q4 EPS; Comps Rose 5.4%
- News Corp (NWSA) to Acquire Move (MOVE) for $21/Share
- Apple (AAPL) iPhone 6/6+ Available In China Starting October 17
- After-Hours Stock Movers 9/29: (CPRX) (BLDP) (PGNX) Higher; (DWA) (SVU) (TSL) Lower (more...)
Pluristem Therapeutics, Inc. (NASDAQ: PSTI) has received FDA orphan status for aplastic anemia treatment.
You May Also Be Interested In
- UPDATE: Alimera Sciences (ALIM), pSivida (PSDV) Win FDA Approval for Iluvien as Chronic DME Treatment
- CytRx (CYTR) Initiates Aldoxorubicin Phase 2b vs. Topotecan in SCLC
- U.S. Law Enforcement Aim to Reverse Apple (AAPL), Google (GOOG) User-Privacy Decision
Create E-mail Alert Related CategoriesFDA, Insiders' Blog
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!